Pre-CAAP Company: Winterlight Labs Closes the First Tranche of $500,000 in seed funding from Novatio Ventures

Ontario Industry Updates
Written By Guest User

WinterLight Labs, a Toronto-based company commercializing a speech-based platform for accurately detecting cognitive conditions such as dementia and Alzheimer’s Disease, recently closed the first tranche of $500,000 in seed funding from Novatio Ventures, an early stage life sciences investment firm.

For the full press release click here

Guest User
Previous

CAAP Company: QoC Health Featured in Canadian Medical Association Journal
Next

Pre-CAAP Company: Akira is Expanding Across Canada